Core Viewpoint - The legal opinion issued by Beijing Tianyuan Law Firm confirms that the differentiated dividend distribution plan of Beijing Zhaoyan New Drug Research Center Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [10]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the company's 2024 annual profit distribution plan, which proposes a cash dividend of 0.3 yuan per 10 shares, calculated on the total share capital after excluding repurchased shares [8][9]. - The total net profit attributable to shareholders for the year 2024 is reported to be approximately 74.08 million yuan, with the proposed cash dividend representing 30.22% of this net profit [8][9]. - The company has confirmed that the total number of shares eligible for profit distribution is 746,174,300 shares after accounting for repurchased shares [8][9]. Group 2: Share Repurchase Plans - The company initiated a share repurchase plan in 2021, intending to use its own funds to repurchase shares for employee incentive plans, with a total repurchase amount between 4 million and 8 million yuan [4]. - In 2024, a new share repurchase plan was approved, allowing for a repurchase amount between 50 million and 100 million yuan, with a maximum repurchase price set at 150% of the average trading price over the previous 30 trading days [5][6]. - As of July 18, 2025, the company holds a total of 3,303,034 shares in its repurchase account, which does not participate in profit distribution [6][9]. Group 3: Legal Compliance and Due Diligence - The law firm conducted thorough due diligence to ensure that the differentiated dividend distribution adheres to the Company Law, Securities Law, and relevant regulatory guidelines [10]. - The legal opinion emphasizes that all provided documents and statements are accurate and complete, with no material omissions or misrepresentations [3][10]. - The firm confirms that the differentiated dividend distribution does not violate any laws or harm the interests of the company and its shareholders [10].

Core Viewpoint - Wuxi Shengjing Microelectronics Co., Ltd. has announced a cash dividend distribution plan for the fiscal year 2024, with a proposed cash dividend of 0.1001 CNY per share, amounting to a total distribution of approximately 10.07 million CNY, which represents 43.94% of the net profit attributable to shareholders [1][2][3]. Dividend Distribution Plan - The cash dividend of 0.1001 CNY per share will be distributed to all shareholders registered by the equity registration date [1][2]. - The total number of shares eligible for the dividend is 100,567,367 shares after excluding 99,300 shares held in the company's repurchase account [3]. - The dividend distribution was approved at the annual general meeting held on June 9, 2025 [1]. Relevant Dates - The key dates for the dividend distribution are as follows: - Equity registration date: August 6, 2025 - Last trading day: August 7, 2025 - Ex-dividend date: August 7, 2025 [1][4]. Tax Implications - For individual shareholders holding shares for more than one year, the dividend income is exempt from personal income tax. For those holding shares for less than one month, the full dividend is subject to a 20% tax rate [7]. - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied to their dividend income, resulting in a net dividend of 0.09009 CNY per share after tax [8][9]. Implementation of Dividend Distribution - The cash dividends will be distributed through the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, to shareholders who have completed designated transactions [6]. - Shareholders who have not completed designated transactions will have their dividends held by the clearing company until the transactions are completed [6].

Core Viewpoint - The company, Wuxi Shengjing Microelectronics Co., Ltd., is implementing a differentiated dividend distribution plan due to the repurchase of shares, which will not participate in profit distribution, ensuring compliance with relevant regulations and protecting shareholder rights [1][6]. Summary by Sections 1. Reason for Differentiated Dividend - The company has approved a share repurchase plan using its own and raised funds, with a total repurchase amount between RMB 30 million and RMB 50 million, at a price not exceeding RMB 51.58 per share, within a 12-month period [1]. 2. Differentiated Dividend Plan - The company plans to distribute a cash dividend of RMB 0.10 per share (tax included) for the fiscal year 2024, with adjustments to be made if the total share capital changes due to various corporate actions [2][3]. 3. Calculation of Differentiated Dividend Indicators - The cash dividend per share has been adjusted to RMB 0.1001 based on the principle of maintaining the total distribution amount unchanged, with a total cash dividend payout of approximately RMB 10.07 million [3][4]. 4. Impact on Ex-Dividend Price - The reference price for ex-dividend trading is calculated based on the previous closing price minus the cash dividend, with the impact of the differentiated dividend on the reference price being minimal, less than 1% [5][6]. 5. Compliance and Verification - The sponsor institution has verified that the differentiated dividend distribution complies with relevant laws and regulations, confirming that it does not harm the interests of the company or its shareholders [6].

Core Viewpoint - The legal opinion issued by Guohao Law Firm confirms that Shanghai Honglida Information Technology Co., Ltd.'s differentiated dividend distribution plan complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][4][5]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is based on the regulations of the Repurchase Rules and the Guidelines for Repurchase, which state that shares in the repurchase account do not have rights to profit distribution [2][3]. - As of September 3, 2024, the company has repurchased a total of 1,301,916 shares through centralized bidding [2]. Group 2: Dividend Distribution Plan - The company plans to distribute a cash dividend of 3.4 yuan (including tax) for every 10 shares based on the total share capital minus the repurchased shares [3][4]. - The total number of shares eligible for profit distribution is 138,698,084 after excluding the repurchased shares from the total share capital of 140,000,000 [4]. Group 3: Calculation Basis for Differentiated Dividend - The reference price for ex-dividend is calculated as (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [4]. - The actual cash dividend distributed is calculated to be approximately 0.33684 yuan per share after considering the total eligible shares [5]. Group 4: Conclusion - The legal opinion concludes that the differentiated dividend distribution aligns with the Company Law, Securities Law, Repurchase Rules, and the company's articles of association, with no adverse effects on the company or its shareholders [5].

Core Viewpoint - Spring Medical (688236) has adjusted its 2024 profit distribution cash dividend total to RMB 18,727,390.80 (including tax), with a cash dividend of RMB 0.049 per share, reflecting a minor change due to share buybacks [2][3][5]. Trading Information Summary - On July 25, Spring Medical's stock closed at RMB 22.4, up 7.49%, with a turnover rate of 1.99%, trading volume of 57,300 shares, and a transaction amount of RMB 128 million [1]. - The fund flow on the same day showed a net outflow of RMB 847.16 million from main funds, accounting for 6.63% of the total transaction amount, while retail investors had a net inflow of RMB 934.27 million, representing 7.31% of the total [2][5]. Company Announcement Summary - Spring Medical announced an adjustment in the total cash dividend for 2024 from RMB 18,752,317.40 (including tax) to RMB 18,727,390.80 (including tax) due to changes in the number of shares participating in the profit distribution [2][5]. - The company will distribute a cash dividend of RMB 0.49 per 10 shares (including tax), with the actual number of shares participating in the distribution being 382,191,649 shares [2][3]. Legal Opinion Summary - A special legal opinion from Beijing Wanshang Tianqin Law Firm confirmed that the differentiated dividend distribution for A-shares complies with relevant laws and regulations, and the impact on the ex-dividend price is minimal, below 1% [4].

Group 1 - The core viewpoint of the article is that Citic Securities has conducted a review of Shanghai Kaisa Biotechnology Co., Ltd.'s differentiated dividend distribution plan for 2024, confirming its compliance with relevant laws and regulations [1][5] - The reason for the differentiated dividend distribution is the company's decision to repurchase shares using its own or raised funds, with a total repurchase amount between RMB 10 million and RMB 20 million [1][2] - As of the date of the review, the company has repurchased 2,341,165 shares, accounting for 0.32% of the total share capital of 721,289,794 shares [2][3] Group 2 - The differentiated dividend plan involves distributing a cash dividend of RMB 4 per 10 shares (including tax) to all shareholders, excluding the repurchased shares [2][3] - The total cash dividend to be distributed is approximately RMB 287.58 million (including tax), based on the adjusted total share capital after excluding repurchased shares [3] - The ex-dividend reference price is calculated to be approximately RMB 46.38 per share, with a minimal impact on the stock price due to the dividend distribution [4][5] Group 3 - The review by Citic Securities concludes that the differentiated dividend distribution plan aligns with the Company Law, Securities Law, and relevant self-regulatory guidelines, ensuring no harm to the interests of the company and its shareholders [5]

Core Viewpoint - The article discusses the special verification opinion regarding the differentiated dividend distribution of Haowei Integrated Circuit (Group) Co., Ltd., confirming that the distribution complies with relevant laws and regulations [1][5]. Group 1: Reasons for Differentiated Dividend - The company has conducted multiple share repurchase plans, with total repurchase amounts ranging from RMB 3 billion to RMB 12 billion, and share prices capped between RMB 85 and RMB 100 per share [1]. - As of the latest report, the company has repurchased a total of 15,134,363 shares, which are held in a dedicated repurchase account and do not participate in the dividend distribution [3][4]. Group 2: Dividend Distribution Details - The proposed dividend distribution is set at RMB 2.20 per 10 shares (including tax), based on a total share capital of 1,217,223,785 shares, excluding the repurchased shares [4]. - The actual number of shares participating in the distribution is 1,202,089,422 shares, leading to a calculated ex-dividend reference price of RMB 125.57 per share [4]. Group 3: Conclusion - The special verification opinion concludes that the differentiated dividend distribution aligns with the Company Law, Securities Law, and self-regulatory guidelines, ensuring no harm to the interests of the company and its shareholders [5].

Core Viewpoint - The legal opinion letter issued by King & Wood Mallesons Shanghai Office confirms that the differentiated profit distribution plan proposed by Jin Jiang International Hotel Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][3][7] Group 1: Differentiated Profit Distribution Plan - The differentiated profit distribution plan involves a cash dividend of RMB 3.80 per 10 shares, based on a total share capital of 1,070,044,063 shares, excluding 1,965,760 shares held in the repurchase account [4][6] - The total number of A shares eligible for distribution is 909,453,044 shares after deducting the shares in the repurchase account, while the total number of B shares remains at 156,000,000 shares [5][6] Group 2: Special Ex-Dividend Treatment - The shares in the repurchase account do not participate in profit distribution, as per the regulations outlined in the regulatory guidelines [6] - The ex-dividend reference price is calculated to be RMB 21.83 per share, based on the previous closing price of RMB 22.21 and the cash dividend [6][7] Group 3: Legal Compliance and Conclusion - The legal opinion asserts that the differentiated profit distribution plan adheres to the Company Law, Securities Law, and relevant regulations, with no detrimental effects on the company or its shareholders [3][7] - The opinion letter is intended solely for the purpose of the differentiated profit distribution and cannot be used for any other purpose [3][4]

Core Viewpoint - The legal opinion issued by Beijing Wan Shang Tian Qin Law Firm confirms that the differentiated dividend distribution plan of Beijing Chunli Zhengda Medical Device Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [4][10]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the company's 2024 profit distribution plan, which proposes a cash dividend of 0.49 RMB per 10 shares, with no stock dividends or capital reserve transfers [6][8]. - The total number of shares participating in the distribution is 382,191,649, which includes 287,051,149 A shares and 95,140,500 H shares, after excluding the repurchased shares [8][9]. - The company has repurchased 1,376,851 A shares, accounting for approximately 0.4774% of the total A shares, which do not participate in the dividend distribution [6][8]. Group 2: Legal Compliance and Verification - The law firm conducted thorough verification of the documents and materials provided by the company, ensuring their authenticity and completeness [2][3]. - The legal opinion is strictly based on Chinese laws and regulations, and does not cover any non-legal professional matters such as accounting or finance [3][4]. - The law firm confirms that the differentiated dividend distribution aligns with the provisions of the Company Law, Securities Law, and relevant regulatory guidelines [4][10]. Group 3: Impact on Stock Price - The differentiated dividend distribution is expected to have a minimal impact on the A-share ex-dividend reference price, with the absolute value of the impact being less than 1% [10]. - The calculated A-share ex-dividend reference price is approximately 18.7212 RMB per share, based on the last closing price and the cash dividend [9][10].

中国国际金融股份有限公司 关于富士康工业互联网股份有限公司 中国国际金融股份有限公司（以下简称"保荐机构"或"中金公司"）作为 富士康工业互联网股份有限公司（以下简称"工业富联"或"公司"）首次公开 发行 A 股股票并上市及持续督导的保荐机构，根据《中华人民共和国公司法》 《中华人民共和国证券法》《上市公司股份回购规则》《上海证券交易所上市公 司自律监管指引第 7 号——回购股份》等有关法律法规和规范性文件的要求， 就公司 2024 年度差异化分红事项进行了核查，核查情况及核查意见如下： 一、 本次差异化分红的原因 公司 2024 年年度股东大会审议通过的《关于 <富士康工业互联网股份有限公> 司 2024 年度利润分配预案>的议案》，本次利润分配方案向全体股东每 10 股派 送现金红利 6.40 元(含税)，公司本次不进行送股或资本公积金转增股本。 根据《富士康工业互联网股份有限公司 2019 年股票期权与限制性股票激励 计划(草案修订稿)》有关规定，公司分别于 2023 年 12 月 31 日召开的第三届董 事会第七次会议、于 2024 年 4 月 30 日召开的第三届董事会第十一次会议、于 开的第三届董 ...